Sandoz falls after Q1 sales growth lower than expected

Sandoz AG

29/04/2026 08:57

** Shares of Sandoz SDZ.S fall 4.15% after the Swiss pharmaceutical company reports first quarter results

** Stock on track for its worst day since October 2025

** The company reported an 11% increase in net sales growth to $2.75 billion year on year

** At constant currency, net sales rose only 3%

** JP Morgan analysts say Q1 sales growth came in at the lower end of expectations but call the guidance reiteration assuring

 (Reporting by Simon Ferdinand Eibach)

 ((Simonferdinand.eibach@thomsonreuters.com))